“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
Zacks Investment Research on MSN
10x Genomics begins Atera shipments as spatial biology demand rises
10x Genomics, Inc. TXG recently began commercial shipments of Atera, its next-generation spatial biology platform designed to combine whole-transcriptome analysis, sub-cellular resolution and ...
Spatial technologies preserve tissue context to guide therapeutic development and translate molecular insights into ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
10x Genomics announced the launch of Atera, a new in situ spatial biology platform designed to deliver whole-transcriptome analysis with single-cell sensitivity at unprecedented scale. The Atera ...
Debuts at AACR Annual Meeting 2026 with Data from Leading Research Institutions, Including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research ...
Multiomics analysis combines data from two or more omics layers—such as genomics, transcriptomics, proteomics, and ...
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results